• SENSEX
    NIFTY 50
Business

Cipla, Dr Reddy's, Carlyle and Hong Kong fund in fray for Wockhardt divisions

Updated : November 18, 2019 11:06 AM IST

Wockhardt has a diversified product portfolio with presence in therapeutic segments such as cardiology, dermatology, diabetes, respiratory and ophthalmology. It is not clear which of these divisions will be sold.
The company had a total debt of Rs 3,367 crore as on March 31, 2019, and its current market capitalisation stands at Rs 3,022 crores.
Cipla, Dr Reddy's, Carlyle and Hong Kong fund in fray for Wockhardt divisions

You May Also Like

Live TV
Advertisement